Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 156.98 million compared to CNY 167.89 million a year ago. Revenue was CNY 171 million compared to CNY 168.14 million a year ago.

Net income was CNY 30.27 million compared to CNY 26.28 million a year ago. Basic earnings per share from continuing operations was CNY 0.047 compared to CNY 0.0408 a year ago. Diluted earnings per share from continuing operations was CNY 0.047 compared to CNY 0.0408 a year ago.